This study sought to genetically define the first family diagnosed with neuronal ceroid lipofuscinosis from Qatar. Onset was in late infancy (3 years), and sequencing in the affected children revealed a novel homozygous c.613C>T change in exon 3 of ceroid-lipofuscinosis, neuronal 5, corresponding to a missense mutation of a conserved amino acid, p.Pro205Ser. The clinical manifestations of the disease in this family largely resemble those of ceroid-lipofuscinosis, neuronal 5 disease, variant late infantile that was first described in Finland and include mental decline, visual deterioration, ataxia, and epileptic seizures. This description of ceroid-lipofuscinosis, neuronal 5 disease in an Arab family adds to the clinical and molecular diversity of the variant late-infantile neuronal ceroid lipofuscinoses, which were originally reported in Europe and are increasingly recognized in other populations.
Haltia M.The neuronal ceroid-lipofuscinoses: from past to present. Biochim Biophys Acta. 2006;1762:850-856.
2.
Williams RE, Aberg L., Autti T., et al. Diagnosis of the neuronal ceroid lipofuscinoses: an update. Biochim Biophys Acta. 2006; 1762:865-872.
3.
Siintola E., Lehesjoki AE, Mole SEMolecular genetics of the NCLs: status and perspectives. Biochim Biophys Acta. 2006; 1762:857-864.
4.
Siintola E., Topcu M., Aula N., et al. The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter. Am J Hum Genet. 2007;81:136-146.
Savukoski M. , Klockars T., Holmberg V., et al. CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat Genet. 1998;19:286-288.
7.
Holmberg V., Lauronen L., Autti T., et al. Phenotype-genotype correlation in eight patients with Finnish variant late infantile NCL (CLN5). Neurology. 2000;55:579-581.
8.
Pineda-Trujillo N., Cornejo W., Wheeler RB, et al. A CLN5 mutation causing an atypical neuronal ceroid lipofuscinosis of juvenile onset. Neurology . 2005;64:740-742.
9.
Bessa C., Teixeira CA, Mangas M., et al. Two novel CLN5 mutations in a Portuguese patient with vLINCL: insights into molecular mechanisms of CLN5 deficiency. Mol Genet Metab. 2006;89: 245-253.
10.
Cismondi IA , Cannelli N., Aiello C., et al. Novel human pathological mutations: gene symbol: CLN5: neuronal ceroid lipofuscinosis, Finnish variant. Hum Genet. 2008;123:537-555.
11.
Lebrun AH, Storch S., Ruschendorf F., et al. Retention of lysosomal protein CLN5 in the endoplasmic reticulum causes neuronal ceroid lipofuscinosis in Asian sibship. Hum Mutat.2009;30:E651-E661.
12.
Sleat DE, Ding L., Wang S., et al. Mass spectrometry-based protein profiling to determine the cause of lysosomal storage diseases of unknown etiology. Mol Cell Proteomics. 2009;8:1708-1718.
13.
Xin W., Mullen TE, Kiely R., et al. CLN5 mutations are frequent in juvenile and late-onset non-Finnish patients with NCL. Neurology. 2010;74:565-571.
14.
Kousi M., Siintola E., Dvorakova L., et al. Mutations in CLN7/ MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis. Brain. 2009 ;132:810-819.
15.
Goldberg-Stern H., Halevi A., Marom D., et al. Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs. Pediatr Neurol. 2009 ;41:297-300.
16.
Koul R., Al-Futaisi A., Ganesh A., Rangnath Bushnarmuth S.Late-infantile neuronal ceroid lipofuscinosis (CLN2/Jansky-Bielschowsky type) in Oman. J Child Neurol. 2007;22:555-559.
17.
Al-Muhaizea MA, Al-Hassnan ZN, Chedrawi A.Variant late infantile neuronal ceroid lipofuscinosis (CLN6 gene) in Saudi Arabia. Pediatr Neurol. 2009;41:74-76.
18.
Aldahmesh MA , Al-Hassnan ZN, Aldosari M., Alkuraya FSNeuronal ceroid lipofuscinosis caused by MFSD8 mutations: a common theme emerging. Neurogenetics. 2009;10:307-311.
19.
Zelnik N., Mahajna M., Iancu TC, et al. A novel mutation of the CLN8 gene: is there a Mediterranean phenotype? Pediatr Neurol. 2007;36:411-413.
20.
Siintola E. , Partanen S., Strömme P., et al. Cathepsin D deficiency underlies congenital human neuronal ceroid lipofuscinosis. Brain. 2006;129:1438-1445.
21.
Steinfeld R. , Reinhardt K., Schreiber K., et al. Cathepsin D deficiency is associated with a human neurodegenerative disorder. Am J Hum Genet. 2006;78:988-998.
22.
Waliany S., Das AK, Gaben A., et al. Identification of three novel mutations of the palmitoyl-protein thioesterase-1 (PPT1) gene in children with neuronal ceroid-lipofuscinosis . Hum Mutat. 2000; 15:206-207.
23.
Das AK, Becerra CHR, Yi W., et al. Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.SJ Clin Invest. 1998;102:361-370.
24.
Das AK, Lu JY, Hofmann SLBiochemical analysis of mutations in palmitoyl-protein thioesterase causing infantile and late-onset forms of neuronal ceroid lipofuscinosis. Hum Mol Genet. 2001; 10:1431-1439.
25.
Simonati A. , Tessa A., Bernardina BD, et al. Variant late infantile neuronal ceroid lipofuscinosis because of CLN1 mutations. Pediatr Neurol. 2009;40:271-276.
26.
Bonsignore M., Tessa A., Rosa GD, et al. Novel CLN1 mutation in two Italian sibs with late infantile neuronal ceroid lipofuscinosis . Eur J Paediatr Neurol. 2006;10:154-156.
27.
Mole SE, Zhong NA, Sarpong A., et al. New mutations in the neuronal ceroid lipofuscinoses. Eur J Paediatr Neurol. 2001;5(supplA):7-10.
28.
Mole SE, Williams RE, Goebel HHCorrelations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics . 2005;6:107-126.
29.
Santavuori P., Rapola J., Nuutila A., et al. The spectrum of Jansky-Bielschowsky disease. Neuropediatrics. 1991;22:92-96.
